Pfizer and BioNTech have urged the US Patent and Trademark Office (USPTO) to reconsider and potentially invalidate Moderna's core COVID-19 vaccine technology patents, asserting they claim pre-existing knowledge. This is the latest development in an ongoing legal battle initiated by Moderna against the two companies in 2022 over alleged patent infringements.
